Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma: a Single Arm, Multicentre Trial.
Latest Information Update: 04 Aug 2023
At a glance
- Drugs Catequentinib (Primary) ; Cisplatin; Paclitaxel
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 21 Jan 2023 Updated results on efficacy and safety presented at the 2023 Gastrointestinal Cancers Symposium
- 22 Jan 2022 Results presented at the 2022 Gastrointestinal Cancers Symposium
- 23 Aug 2021 Planned End Date changed from 1 Oct 2022 to 1 Jun 2022.